- Home
- POWW vs DERM Comparison
POWW vs DERM Comparison
Compare POWW & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | POWW | DERM |
|---|---|---|
| Founded | 1990 | 2014 |
| Country | United States | United States |
| Employees | 81 | N/A |
| Industry | Ordnance And Accessories | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 225.2M | 267.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | POWW | DERM |
|---|---|---|
| Price | $2.02 | $6.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $2.40 | ★ $12.67 |
| AVG Volume (30 Days) | ★ 754.3K | 114.9K |
| Earning Date | 02-09-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $56,134,000.00 |
| Revenue This Year | $14.56 | $17.48 |
| Revenue Next Year | $0.50 | $55.83 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.08 | $5.51 |
| 52 Week High | $2.23 | $9.56 |
Technical Indicators
Market Signals| Indicator | POWW | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 50.69 | 36.54 |
| Support Level | $1.99 | $6.77 |
| Resistance Level | $2.20 | $7.92 |
| Average True Range (ATR) | 0.09 | 0.47 |
| MACD | -0.02 | -0.11 |
| Stochastic Oscillator | 31.48 | 19.05 |
Price Performance
Historical ComparisonAbout POWW AMMO Inc.
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.